All dose values on this page come from the Phase 2 trial (Jastreboff et al., NEJM 2023) or are arithmetic derivations from that titration ladder
Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV
After that, the membranes including the goal proteins were incubated with the corresponding antibody including anti-ANP antibody (abcam, Cambridge, MA, USA) diluted 1: 5000, anti-MYH7 antibody (Proteintech Group, Inc, Wuhan, China) diluted 1: 2000, anti-COXII antibody (Cell Signaling Technology, Inc, Boston, USA) diluted 1: 1000, anti-LC3B antibody (Abclonal, Wuhan, China) diluted 1: 2000, anti-GAPDH antibody (abcam, Cambridge, MA, USA) diluted 1: 10,000, anti-NLRP3 antibody (Abclonal, Wuhan, China) diluted 1: 2000, anti-IL-18 antibody (Abclonal, Wuhan, China) diluted 1: 2000, and anti-Caspase-1 antibody (Proteintech Group, Inc, Wuhan, China) diluted 1: 2000 for at least 16 h

10.1007/s11095-007-9488-9 Summary Keywords bioavailability, elimination half-life, ingestible injection devices, macrocyclic peptides, MK-0616, negative selection, octreotide, oral peptide delivery Citation Niazi SK (2026) Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage
Dubelaar ML et al
Because the 0.9% benzyl alcohol keeps the solution sterile through repeated withdrawals, bac water for peptides is preferred over plain sterile water whenever a vial will be accessed more than once over its shelf life